AFMR Partners:

AFMR Members Final Dues Reminder
If you have not yet renewed your AFMR dues - your subscription to the Journal of Investigative Medicine is about to end! Renew now so you won't miss an issue.
Contact your congressperson
NIH
|
 |
NIH Director's Response to Stem Cell Injunction
"Human embryonic stem cell research holds great promise for the development of treatments for people threatened by potentially curable diseases. The recent court ruling that halted the federal funding of human embryonic stem cell research could cause irreparable damage and delay potential breakthroughs to improve care for people living with serious diseases and conditions such as spinal cord injury, diabetes, or Parkinson's disease. The injunction threatens to stop progress in one of the most encouraging areas of biomedical research, just as scientists are gaining momentum--and squander the investment we have already made. The possibility of using these cells to replace those that have been damaged by disease or injury is one of the most breathtaking advances we can envision. Human embryonic stem cells also represent a powerful new approach to the early stages of screening for new drugs, and may hold the secrets to creating entirely new, targeted clinical therapies. We must move forward--without delay--to sustain this field of research that provides so much hope for thousands of patients and their families."
Francis S. Collins, M.D., Ph.D., Director, National Institutes of Health
The National Institutes of Health (NIH) -- The Nation's Medical Research Agency -- includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services.
It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases.
For more information about NIH and its programs, visit www.nih.gov.
This Statement from the NIH Director is available online at:
http://www.nih.gov/about/director/08262010statement_stemcellinjunction.htm.
FASEB Expresses Disappointment In Stem Cell Ruling
Bethesda, MD – The Federation of American Societies for Experimental Biology (FASEB) is profoundly disappointed in the Federal District Court injunction barring federal funds for human embryonic stem cell research. “The decision is a huge blow to potentially life-saving biomedical research,” said FASEB President, William T. Talman, M.D. Read more here.
Call for Nominations - 2011 Alan T. Waterman Award
The National Science Foundation is pleased to accept nominations for the 2011 Alan T. Waterman Award. Each year, the Foundation bestows the Waterman Award to recognize the talent, creativity, and influence of a singular young researcher. Details about the Waterman award’s history, the nomination procedure and the selection criteria are available below.
Nominees are accepted from any field of science or engineering that NSF supports. Nominations must be submitted electronically using NSF's FastLane system at https://www.fastlane.nsf.gov/honawards/index.jsp. Please direct all inquiries about the award and the nomination procedures to Mayra Montrose (mmontros@nsf.gov).
A PDF version of the call for nominations is available here.
NIH Announces Principal Deputy Director
The AFMR is a member of Research!America, the nation’s largest not-for-profit public education and advocacy alliance. Research!America focuses on advocacy, leadership, outreach, public opinion polls and public education as they relate to medical research. To learn more about Research!America and how you, as a modern day medical researcher, may become involved with the organization, please visit http://www.researchamerica.org/. Read the April 2010 edition of their newsletter, The Research Advocate.
AFMR Career Connections
AFMR is pleased to announce that it has created A Career Connections site that addresses individual career development, research and training opportunities, career opportunities, funding sources, and grant development.
|
AFMR is pleased to announce a new Public Section of our website:
For the Public
|
Online dues renewal is now available. Members in good standing receive discounted registration at all AFMR meetings and a subscription to the Journal of Investigative Medicine. Renew today!
The remit to address for Dues payments has changed to:
900 Cummings Center, Suite 221-U, Beverly, MA 01915
|
|